Generic drug maker Lotus Pharmaceuticals Co (美時化學製藥) yesterday said it has made non-material adjustments to its financial statements for 2016 and 2017 after South Korean regulators found minor accounting errors at its subsidiary there.
The subsidiary, Alvogen Korea Co Ltd, was included in an industry-wide probe by the South Korean Financial Supervisory Service (FSS), following a high-profile case in April last year against alleged accounting violations at Samsung BioLogics Co, the biotechnology arm of the South Korean tech giant.
Lotus Pharmaceuticals has since revised its earnings, resulting in a NT$15 million (US$493,729) decrease in its 2016 net income and a NT$14 million increase in 2017, the local firm said.
Following the adjustments, the company reported a net loss of NT$0.63 per share for 2016, compared with a previous net loss of NT$0.56 per share.
For 2017, the company’s earnings per share inched up from NT$0.03 to NT$0.09.
The company said that the error is rooted in the difference of interpretation on South Korea’s international financial reporting standards principles regarding development costs of the company’s Incremental Modified Drug (IMD) pipeline.
IMD, or more widely known as 505(b)(2), is an alternative US Food and Drug Administration approval pathway designed to allow the approval of a drug that is not new, but still differs in several meaningful aspects.
While the classification of IMD as generic or new drug products remains a debated area among accounting experts, the company said it has accepted the decision of the FSS.
IMD falls between New Drug Application that is seeking approval to introduce a new drug to the market and Abbreviated New Drug Application (ANDA), which aims to gain approval for a generic version of a drug that is already on the market, according to US FDA guidelines.
The FSS in November last year fined Samsung Biologics US$7.04 million and recommended dismissing its chief executive officer for deliberately overstating the value of its affiliate ahead of the unit’s initial public offering that later raised about US$2 billion.
Lotus Pharmaceuticals has reported that sales in the past month rose 0.7 percent annually to NT$529 million, while aggregate sales in the past year rose 1.1 percent annually to NT$6.35 billion.
Higher generic drug demand from Taiwan and overseas helped offset the loss of licensing fee income, while the introduction of its new Lenalidomide chemotherapy to markets in Europe, the Middle East and Asia would help support sales growth this quarter, the industry’s slow season, the company said.
Taiwan Transport and Storage Corp (TTS, 台灣通運倉儲) yesterday unveiled its first electric tractor unit — manufactured by Volvo Trucks — in a ceremony in Taipei, and said the unit would soon be used to transport cement produced by Taiwan Cement Corp (TCC, 台灣水泥). Both TTS and TCC belong to TCC International Holdings Ltd (台泥國際集團). With the electric tractor unit, the Taipei-based cement firm would become the first in Taiwan to use electric vehicles to transport construction materials. TTS chairman Koo Kung-yi (辜公怡), Volvo Trucks vice president of sales and marketing Johan Selven, TCC president Roman Cheng (程耀輝) and Taikoo Motors Group
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
RECORD-BREAKING: TSMC’s net profit last quarter beat market expectations by expanding 8.9% and it was the best first-quarter profit in the chipmaker’s history Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), which counts Nvidia Corp as a key customer, yesterday said that artificial intelligence (AI) server chip revenue is set to more than double this year from last year amid rising demand. The chipmaker expects the growth momentum to continue in the next five years with an annual compound growth rate of 50 percent, TSMC chief executive officer C.C. Wei (魏哲家) told investors yesterday. By 2028, AI chips’ contribution to revenue would climb to about 20 percent from a percentage in the low teens, Wei said. “Almost all the AI innovators are working with TSMC to address the
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”